Gilead licenses remdesiver production to India and Pakistan

NEW DELHI — U.S.-based Gilead Sciences has tied up with India’s Cipla and Jubilant Life Sciences, Pakistan’s Ferozsons Laboratories and two other generic pharmaceutical makers to ramp up the supply of remdesivir, its closely watched investigational coronavirus drug.

The non-exclusive voluntary licensing agreements allow the partner companies to produce remdesivir for distribution in 127 countries, Gilead said in a statement. “The countries consist of nearly all low-income and lower-middle-income countries, as well as several upper-middle- and high-income countries that face significant obstacles to healthcare access,” the statement says.

These nations include Afghanistan, Bangladesh, Cambodia, Egypt, Fiji, India, Indonesia, Myanmar, Nepal,

Read More

Singapore’s 5G in 5 years plan on track as licenses granted

SINGAPORE — Singapore’s three largest wireless carriers have won approval to operate 5G networks, setting in motion plans to provide coverage across the island-nation within the next five years.

Singapore Telecommunications, or Singtel, the city state’s leading telecom provider, was awarded a provisional license along with a joint bid by StarHub Mobile and M1, the No. 2 and No. 3 players, the government’s telecommunication authority announced Wednesday.

After completing processes, such as assigning frequency spectrums and selecting equipment suppliers, the operators will receive formal licenses as early as June.

Service is due to launch in January next year. The winning

Read More